Most fertility clinics prescribe estradiol until about 10 to 12 weeks of gestation after a frozen embryo transfer. The exact stop date varies by clinic protocol, cycle type, and individual circumstances, but that 10-to-12-week window is the standard range you’ll encounter. For fresh embryo transfers, estradiol supplementation is often unnecessary altogether.
Why Estradiol Is Prescribed After Transfer
Estradiol’s main job is building and maintaining the uterine lining. It stimulates the growth of cells within the endometrium, creating the thick, blood-rich environment an embryo needs to implant and develop. It also works alongside progesterone to shift the lining from a growth phase into a receptive, secretory state that supports early pregnancy.
In a frozen embryo transfer (FET) using a hormone replacement protocol, your ovaries aren’t producing these hormones on their own. There’s no natural ovulation cycle driving lining development, and often no functional corpus luteum (the temporary gland that normally produces estrogen and progesterone after ovulation). That means your body depends entirely on the supplemental hormones you’re taking to sustain the pregnancy in those early weeks.
Fresh Transfers Are Different
If you had a fresh transfer, you likely went through ovarian stimulation, which means your ovaries are already producing high levels of estrogen on their own. A meta-analysis of nine randomized controlled trials found that adding estrogen supplementation to progesterone after a fresh transfer didn’t improve ongoing pregnancy rates, regardless of how the estrogen was given. This is why many clinics skip estradiol entirely for fresh cycles and rely on progesterone alone for luteal phase support.
Frozen transfers are the cycles where estradiol supplementation is routine and essential, since the hormone replacement protocol suppresses your body’s own follicle development and estrogen production from the start.
When Your Placenta Takes Over
The reason supplemental estradiol has an end date is a biological milestone called the luteal-placental shift. During the first trimester, the placenta gradually takes over hormone production from the corpus luteum (or, in FET cycles, from your medications). In a typical singleton pregnancy, this transition happens when pregnancy hormone levels peak between 6 and 8 weeks of gestation, then begin to decline. After that decline, the placenta becomes the primary source of both progesterone and estrogen.
This shift is why most protocols target the end of the first trimester as the discontinuation point. By 10 to 12 weeks, the placenta is reliably producing enough hormones to sustain the pregnancy on its own.
The 6-Week vs. 12-Week Question
There’s growing interest in whether estradiol can be stopped earlier than 12 weeks. In a randomized controlled trial published in Archives of Gynecology and Obstetrics, researchers assigned 64 pregnant women to two groups after confirming a gestational sac and heartbeat at 6 weeks. One group stopped estradiol immediately at that point. The other continued it until 12 weeks. Both groups continued progesterone injections through week 12.
The study found that earlier discontinuation of estradiol “may be taken into consideration,” though the authors noted that additional studies are needed to pinpoint the optimal stopping time. This is one reason you might hear different timelines from different clinics. Some stop estradiol around 8 weeks, others hold to 10 or 12 weeks, and the evidence hasn’t yet settled on a single best practice.
What’s consistent across protocols is that progesterone typically continues through 10 to 12 weeks even if estradiol is stopped earlier. The two hormones don’t always share the same discontinuation date.
How Estradiol Is Taken
Estradiol for FET support comes in several forms: oral tablets, transdermal patches, and vaginal inserts. Some clinics use a fixed dose throughout the cycle, while others use an increasing-dose approach that mimics the natural rise in estrogen during a menstrual cycle. Research comparing these strategies has not found a meaningful difference in live birth rates between the approaches, so your clinic’s choice likely comes down to preference, cost, and how well you tolerate a given method.
The duration of use doesn’t typically change based on which form you’re taking. Whether you’re on patches or pills, the stop date is driven by gestational age and your clinic’s protocol, not the delivery method.
Stopping: Gradual vs. All at Once
Clinics handle discontinuation differently. Some instruct you to stop estradiol abruptly, while others taper the dose over days or weeks. Research on hormone therapy discontinuation (in broader contexts, not just IVF) has found no clear winner between the two methods. Tapering may produce fewer rebound symptoms like hot flashes, but women who taper are also more likely to feel dependent on the medication and hesitate to fully stop.
In IVF specifically, your clinic will give you a clear plan. If you’re told to stop at a certain date, that decision is typically tied to an ultrasound milestone, most commonly confirmation of a heartbeat and appropriate growth. Don’t adjust your stop date on your own, since the timing is calibrated to your specific cycle and how your pregnancy is progressing.
What to Expect When You Stop
Some women notice mild symptoms after discontinuing estradiol, including headaches, mood shifts, or light spotting. These are related to the drop in external hormone levels and are generally short-lived, since the placenta is already producing its own supply by this point. Spotting in particular can be alarming but is common during the transition off supplemental hormones and doesn’t necessarily indicate a problem.
The key clinical checkpoints that typically precede discontinuation are a confirmed heartbeat on ultrasound and gestational age reaching the target week in your protocol. If your clinic stops estradiol before progesterone, you’ll continue progesterone support for the remaining weeks until that medication is also discontinued, usually by the end of week 12.